FDA Approved: ABIRATERONE ACETATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Abiraterone Acetate from Mylan Pharmaceuticals Inc., supporting the availability of a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)

Snippet

SUPPL AP for ABIRATERONE ACETATE (ABIRATERONE ACETATE)